Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
monomethoxypolyethylene glycol-modified house dust mite extract
- Development stage
- Unknown
- Modality
- Biodegradable Polymers → Polymer-based Nanoparticles → Nanoparticles → Drug Delivery Systems, Vaccines & Immunotherapeutics
- Administration
- Subcutaneous
01
Overview
Monomethoxypolyethylene glycol-modified house dust mite extract is a chemically modified allergen preparation in which proteins from the house dust mite (Dermatophagoides pteronyssinus) are covalently coupled to monomethoxypolyethylene glycol (mPEG). This modification aims to reduce the allergenicity of the native extract while retaining its immunogenic properties for use in allergen-specific immunotherapy (hyposensitization) for patients with confirmed allergy to house dust mites. The mPEG modification reduces both immediate allergic reactions and overall clinical reactivity compared to unmodified extracts. It is administered as part of subcutaneous immunotherapy protocols for allergic asthma or rhinitis due to house dust mites[1][2][3][4]. Clinical studies have shown that while mPEG modification decreases allergenicity, it may also reduce clinical efficacy at equal doses compared with non-modified extracts[1].
- Other names
- mPEG-modified house dust mite extractmonomethoxypolyethylene glycol-coupled Dermatophagoides pteronyssinus extractmPEG-Dp extract
02
Targets
House dust mite allergen protein
Beyond the preview
Go deeper on monomethoxypolyethylene glycol-modified house dust mite extract.
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Indications & development
Full profile accessExplore development by indication, patient population, and geography.
- Indications
- Development status
- Countries
Licensing & deals
Full profile accessTrace asset ownership, licensing agreements, and commercial partnerships.
- Partners
- Deal terms
- Milestones
Patents & exclusivity
Full profile accessExplore the patent landscape and regulatory exclusivity around an asset.
- Patents
- Expiration dates
- Exclusivity
Competitive landscape
Full profile accessCompare development programs by target, modality, and indication.
- Competing assets
- Targets
- Development stage
Research & analysis
Full profile accessConnect source evidence and development news to your research questions.
- Publications
- News
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on monomethoxypolyethylene glycol-modified house dust mite extract.